vs
Side-by-side financial comparison of AVANOS MEDICAL, INC. (AVNS) and Riot Platforms, Inc. (RIOT). Click either name above to swap in a different company.
AVANOS MEDICAL, INC. is the larger business by last-quarter revenue ($180.9M vs $152.8M, roughly 1.2× Riot Platforms, Inc.). AVANOS MEDICAL, INC. runs the higher net margin — -0.7% vs -452.0%, a 451.2% gap on every dollar of revenue. On growth, Riot Platforms, Inc. posted the faster year-over-year revenue change (7.2% vs 0.7%). AVANOS MEDICAL, INC. produced more free cash flow last quarter ($21.3M vs $-774.3M). Over the past eight quarters, Riot Platforms, Inc.'s revenue compounded faster (38.8% CAGR vs 4.4%).
Avanos Medical, Inc. is a medical technology company making clinical medical devices. The company consists of two franchises – Pain Management and Chronic Care – that address reducing the use of opioids while helping patients recover faster and preventing infection.
Riot Platforms, Inc. is a leading U.S.-based enterprise focused on Bitcoin mining, operating multiple large-scale, energy-efficient data centers across North America. It also invests in blockchain infrastructure development and holds Bitcoin as a core long-term reserve asset, centering its business strategy around the digital asset ecosystem.
AVNS vs RIOT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $180.9M | $152.8M |
| Net Profit | $-1.3M | $-690.7M |
| Gross Margin | 47.5% | — |
| Operating Margin | 1.4% | -447.9% |
| Net Margin | -0.7% | -452.0% |
| Revenue YoY | 0.7% | 7.2% |
| Net Profit YoY | 99.7% | -606.3% |
| EPS (diluted) | $-0.02 | $-1.89 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $180.9M | $152.8M | ||
| Q3 25 | $177.8M | $180.2M | ||
| Q2 25 | $175.0M | $153.0M | ||
| Q1 25 | $167.5M | $161.4M | ||
| Q4 24 | $179.6M | $142.6M | ||
| Q3 24 | $170.4M | $84.8M | ||
| Q2 24 | $171.7M | $70.0M | ||
| Q1 24 | $166.1M | $79.3M |
| Q4 25 | $-1.3M | $-690.7M | ||
| Q3 25 | $-1.4M | $104.5M | ||
| Q2 25 | $-76.8M | $219.5M | ||
| Q1 25 | $6.6M | $-296.4M | ||
| Q4 24 | $-397.3M | $136.4M | ||
| Q3 24 | $4.3M | $-154.4M | ||
| Q2 24 | $1.8M | $-84.4M | ||
| Q1 24 | $-900.0K | $211.8M |
| Q4 25 | 47.5% | — | ||
| Q3 25 | 48.4% | — | ||
| Q2 25 | 52.6% | — | ||
| Q1 25 | 53.6% | — | ||
| Q4 24 | 54.6% | — | ||
| Q3 24 | 54.5% | — | ||
| Q2 24 | 55.7% | — | ||
| Q1 24 | 57.1% | — |
| Q4 25 | 1.4% | -447.9% | ||
| Q3 25 | 0.1% | 44.4% | ||
| Q2 25 | -42.6% | — | ||
| Q1 25 | 6.1% | -144.9% | ||
| Q4 24 | -233.0% | — | ||
| Q3 24 | 7.0% | -143.3% | ||
| Q2 24 | 3.7% | -167.2% | ||
| Q1 24 | 2.4% | — |
| Q4 25 | -0.7% | -452.0% | ||
| Q3 25 | -0.8% | 58.0% | ||
| Q2 25 | -43.9% | 143.4% | ||
| Q1 25 | 3.9% | -183.6% | ||
| Q4 24 | -221.2% | 95.7% | ||
| Q3 24 | 2.5% | -182.1% | ||
| Q2 24 | 1.0% | -120.6% | ||
| Q1 24 | -0.5% | 267.1% |
| Q4 25 | $-0.02 | $-1.89 | ||
| Q3 25 | $-0.03 | $0.26 | ||
| Q2 25 | $-1.66 | $0.58 | ||
| Q1 25 | $0.14 | $-0.90 | ||
| Q4 24 | $-8.64 | $0.39 | ||
| Q3 24 | $0.09 | $-0.54 | ||
| Q2 24 | $0.04 | $-0.32 | ||
| Q1 24 | $-0.02 | $0.51 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $89.8M | $233.5M |
| Total DebtLower is stronger | $90.3M | $840.8M |
| Stockholders' EquityBook value | $778.2M | $2.9B |
| Total Assets | $1.1B | $3.9B |
| Debt / EquityLower = less leverage | 0.12× | 0.29× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $89.8M | $233.5M | ||
| Q3 25 | $70.5M | $330.7M | ||
| Q2 25 | $90.3M | $255.4M | ||
| Q1 25 | $97.0M | $163.7M | ||
| Q4 24 | $107.7M | $277.9M | ||
| Q3 24 | $89.0M | $355.7M | ||
| Q2 24 | $92.2M | $481.2M | ||
| Q1 24 | $75.8M | $688.5M |
| Q4 25 | $90.3M | $840.8M | ||
| Q3 25 | $93.4M | $5.3M | ||
| Q2 25 | $95.7M | $5.3M | ||
| Q1 25 | $98.0M | $5.3M | ||
| Q4 24 | $125.3M | $584.6M | ||
| Q3 24 | $152.6M | $5.7M | ||
| Q2 24 | $164.9M | — | ||
| Q1 24 | $167.2M | — |
| Q4 25 | $778.2M | $2.9B | ||
| Q3 25 | $778.0M | $3.5B | ||
| Q2 25 | $776.3M | $3.3B | ||
| Q1 25 | $839.4M | $2.9B | ||
| Q4 24 | $828.5M | $3.1B | ||
| Q3 24 | $1.2B | $2.7B | ||
| Q2 24 | $1.2B | $2.6B | ||
| Q1 24 | $1.2B | $2.5B |
| Q4 25 | $1.1B | $3.9B | ||
| Q3 25 | $1.1B | $4.5B | ||
| Q2 25 | $1.0B | $4.3B | ||
| Q1 25 | $1.1B | $3.7B | ||
| Q4 24 | $1.2B | $3.9B | ||
| Q3 24 | $1.7B | $2.9B | ||
| Q2 24 | $1.7B | $2.7B | ||
| Q1 24 | $1.7B | $2.6B |
| Q4 25 | 0.12× | 0.29× | ||
| Q3 25 | 0.12× | 0.00× | ||
| Q2 25 | 0.12× | 0.00× | ||
| Q1 25 | 0.12× | 0.00× | ||
| Q4 24 | 0.15× | 0.19× | ||
| Q3 24 | 0.12× | 0.00× | ||
| Q2 24 | 0.13× | — | ||
| Q1 24 | 0.14× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.2M | $-572.9M |
| Free Cash FlowOCF − Capex | $21.3M | $-774.3M |
| FCF MarginFCF / Revenue | 11.8% | -506.6% |
| Capex IntensityCapex / Revenue | 3.8% | 131.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $43.1M | $-1.4B |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.2M | $-572.9M | ||
| Q3 25 | $14.0M | $-114.0M | ||
| Q2 25 | $6.8M | $-231.3M | ||
| Q1 25 | $25.7M | $-122.1M | ||
| Q4 24 | $57.9M | $-255.1M | ||
| Q3 24 | $23.0M | $-56.3M | ||
| Q2 24 | $27.8M | $-42.5M | ||
| Q1 24 | $-8.0M | $-57.9M |
| Q4 25 | $21.3M | $-774.3M | ||
| Q3 25 | $7.0M | $-139.7M | ||
| Q2 25 | $-4.2M | $-291.7M | ||
| Q1 25 | $19.0M | $-154.9M | ||
| Q4 24 | $53.1M | $-495.4M | ||
| Q3 24 | $20.0M | $-127.6M | ||
| Q2 24 | $21.9M | $-96.1M | ||
| Q1 24 | $-12.1M | $-115.2M |
| Q4 25 | 11.8% | -506.6% | ||
| Q3 25 | 3.9% | -77.5% | ||
| Q2 25 | -2.4% | -190.7% | ||
| Q1 25 | 11.3% | -96.0% | ||
| Q4 24 | 29.6% | -347.5% | ||
| Q3 24 | 11.7% | -150.5% | ||
| Q2 24 | 12.8% | -137.2% | ||
| Q1 24 | -7.3% | -145.2% |
| Q4 25 | 3.8% | 131.8% | ||
| Q3 25 | 3.9% | 14.3% | ||
| Q2 25 | 6.3% | 39.5% | ||
| Q1 25 | 4.0% | 20.4% | ||
| Q4 24 | 2.7% | 168.6% | ||
| Q3 24 | 1.8% | 84.1% | ||
| Q2 24 | 3.4% | 76.5% | ||
| Q1 24 | 2.5% | 72.3% |
| Q4 25 | — | — | ||
| Q3 25 | — | -1.09× | ||
| Q2 25 | — | -1.05× | ||
| Q1 25 | 3.89× | — | ||
| Q4 24 | — | -1.87× | ||
| Q3 24 | 5.35× | — | ||
| Q2 24 | 15.44× | — | ||
| Q1 24 | — | -0.27× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AVNS
| Enteral Feeding | $83.0M | 46% |
| Radiofrequency Ablation | $36.9M | 20% |
| Neonate Solutions | $32.1M | 18% |
| Surgical Pain And Recovery | $24.7M | 14% |
| Corporate Other | $4.2M | 2% |
RIOT
| Bitcoin Mining Segment | $131.7M | 86% |
| Engineering Segment | $21.1M | 14% |
